Complex coronary cases
PCI of LAD CTO-D1 Bifurcation – November 2017

64 year old male presented with new onset CCS Class II angina and a positive stress MPI for anterior, apical and septal ischemia. A Cardiac Cath on November 7, 2017 revealed II Vessel CAD: proximal LAD CTO bifurcation (Medina 1,1,1), with 80% D1 bifurcation, 70% LCx-OM2 with a SYNTAX score of 30.5 and LVEF = 60%. Patient underwent FFR of the LCx, which was 0.91 (-). Patient is now planned for staged PCI of LAD CTO-D1 bifurcation with planned 2-stent technique.

Moderator: Sameer Mehta, MD


Should there be a follow up trial to ORBITA - in Europe?

I agree that we should have 6month followup of the ORBITA trial because pts with +FFR had higher events of urgent revascularization at 5-7 months followup which led to premature termination of FAME II trial.

What do you think will be the long term fate of the patients in the two arms of ORBITA?

I predict that many pts in the Sham PCI group on their own request or recommendation by their treating cardiologist will undergo PCI after 2 months when they were told that they did not have actual PCI.

You feel ORBITA will be old news by next TCT, or sooner?

I think it is already an old news as it did not have the fallout of PCI as we had after COURAGE trial. I still think that some insurance companies may mandate approval of Cath only first and then MMT and will approve PCI only if MMT fails as the second step/stage.

Is there a good message for interventional cardiologists from ORBITA?

Yes a simple message is that, PCI in single vessel CAD should only be done for symptoms of persistent angina, exercise limitation or ischemia on stress testing on MMT.

Will payers get concerned with ORBITA or it makes no major difference as there is no change to guidelines?

I strongly believe that some of the insurance companies start approving coronary angio only and then maximize the Medical therapy (MT). If MT fails then only PCI will be approved. Or simply insurance companies should start mandating FFR measurements before elective PCI for stable pts; that PCI only if lesion has FFR of <0.81. This will be the right thing to do supported by various RCTs.

In 2017, what bifurcation technique is best for LMCA?

Dedicated 2 stent technique is better then provision stenting for LM bifurcation lesions. Preferred Type of 2 stent technique will vary based on the personal experience. Data have shown DK Crush as the preferred approach but requires multiple steps and others like Minicrush or Culotte are relatively simple and are also expected to give similar results. We routinely do Minicrush for distal LM bifurcation with excellent short and long term results (case # 100 was Minicrush for dLM bifurcation).

What are wire passage times for CTO at Mt. Sinai?

Average wire passage time for antegrade CTO wire recanalization at Mount Sinai is 22 minutes along with the mean total procedure time of 55 minutes. Average wire passage time for retrograde recanalization is 45 minutes.

Breakdown for antegrade and retrograde approach of CTO?

We have 95% Antegrade (usually 2 attempts) and 5% Retrograde technique for CTO recanalization at MSH.

Do you think this may happen - during a complex PCI, the operator wants to review the Bifurcaid App?

Bifurcaid App really is a great resource for a practicing interventionalist. It’s main utility will be to plan the case before the actual procedure. In rare situation, if case is not proceeding as planned, it will reasonable to go thru the trouble shoot steps from the App.

Best trial at TCT? Culprit shock?

Three best trials from TCT which will change our Interventional thought process and strategies are Culprit Shock, ORBITA and DK-Crush V.


Join the Discussion

3 thoughts on “PCI of LAD CTO-D1 Bifurcation – November 2017”

  1. Durgaprasad says:

    Thank you so much Sir…

  2. Mallik says:


  3. Muhammad Asghar Khan says:

    Excellent teaching live universal programme. I learned from it and practised it

Leave a Reply

Your email address will not be published. Required fields are marked *

By submitting this form, you are consenting to receive marketing emails from: Mount Sinai Hospital, One Gustave L. Levy Place, Box, New York, NY, 10029, You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Complex prox RCA CTO Recanalization via Retrograde Approach – February 2021
Views 152

56-year-old male presented with Class III unstable angina and positive stress MPI for significant inferior ischemia. A Cardiac Cath on November 20, 2020 at outside hospital revealed 2 V VAD: 85% mid LAD, 70% D1 and CTO proximal RCA with distal vessel fills retrogradely via septal collaterals (J-CTO Score 3), LVEF = 50% and Syntax […]

High-Risk Complex PCI of Diffuse Multivessel CAD – January 2021
Views 467

  Case and Plan: 45-year-old male with multiple CAD risk factors presented to OSH on November 6, 2020 with unstable angina and positive ETT. A Cardiac Cath on November 9, 2020 revealed extensive 3V CAD: 100% mid LAD, 90% D2, 70% proximal LCx, 100% LCx-OM1, 100% mid RCA with LVEF = 60% and SYNTAX Score […]

Extremely Tortuous Angulated mid LAD Diagonal Bifurcation Lesion – December 2020
Views 627

Case and Plan: 75-year-old female presented with new onset CCS Class II angina and positive stress MPI on November 9, 2020 revealing moderate apical and inferior ischemia. A Cardiac Cath on November 24, 2020 revealed 2 V CAD: 95% proximal RCA, angulated tortuous 95% mid LAD bifurcation lesion, LVEF = 60% and SYNTAX Score = […]

Staged PCI of RCA multilayer DES CTO ISR using rotational atherectomy and IVBT – November 2020
Views 379

Case and Plan: 65-year old male with known long standing history of chronic ischemic heart disease requiring multiple PCI’s over the years after declining CABG, presented with CCS Class III angina and high risk stress MPI for multivessel ischemia. A Cardiac Cath on September 28, 2020 revealed 3 V CAD: 100% proximal RCA due to […]